Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, has ...

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...

Reuters is tracking how companies are responding to the threat posed by <a href=" target="_blank" rel="noopener noreferrer ...

The Onyear Betel Nut Processing Plant project is recognized as a benchmark initiative, promoting 3D digital design and ...